{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:18:40Z","timestamp":1785914320109,"version":"3.56.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejps.2024.106712","type":"journal-article","created":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T17:33:33Z","timestamp":1706463213000},"page":"106712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Application of nanofiber-based drug delivery systems in improving anxiolytic effect of new 1,2,3-triazolo-1,4-benzodiazepine derivatives"],"prefix":"10.1016","volume":"195","author":[{"given":"Iryna","family":"Botsula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"S\u0441havikin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5996-5144","authenticated-orcid":false,"given":"Jyrki","family":"Hein\u00e4m\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Laidm\u00e4e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryna","family":"Mazur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ain","family":"Raal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleh","family":"Koshovyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Kireyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentyn","family":"Chebanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2024.106712_bib0001","series-title":"Diagnostic and Statistical Manual of Mental Disorders","first-page":"215","article-title":"Anxiety Disorders","year":"2022"},{"key":"10.1016\/j.ejps.2024.106712_bib0002","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2147\/NDT.S36453","article-title":"Pregabalin for the treatment of generalized anxiety disorder: an update","volume":"9","author":"Baldwin","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.ejps.2024.106712_bib0003","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jconrel.2020.07.038","article-title":"Progress in the design and development of \"fast-dissolving\" electrospun nanofibers based drug delivery systems - a systematic review","volume":"326","author":"Balusamy","year":"2020","journal-title":"J. Control Release"},{"issue":"3","key":"10.1016\/j.ejps.2024.106712_bib0004","doi-asserted-by":"crossref","first-page":"327","DOI":"10.31887\/DCNS.2015.17.3\/bbandelow","article-title":"Epidemiology of anxiety disorders in the 21st century","volume":"17","author":"Bandelow","year":"2015","journal-title":"Dialogues. Clin. Neurosci."},{"issue":"9","key":"10.1016\/j.ejps.2024.106712_bib0005","doi-asserted-by":"crossref","first-page":"e02446","DOI":"10.1016\/j.heliyon.2019.e02446","article-title":"Study of novel triazolo-benzodiazepine analogues as antidepressants targeting by molecular docking and ADMET properties prediction","volume":"5","author":"Belhassan","year":"2019","journal-title":"Heliyon."},{"issue":"5","key":"10.1016\/j.ejps.2024.106712_bib0006","doi-asserted-by":"crossref","first-page":"152","DOI":"10.18773\/austprescr.2015.055","article-title":"Management of benzodiazepine misuse and dependence","volume":"38","author":"Brett","year":"2015","journal-title":"Aust. Prescr."},{"issue":"28","key":"10.1016\/j.ejps.2024.106712_bib0007","doi-asserted-by":"crossref","first-page":"74","DOI":"10.15587\/2519-4852.2020.222511","article-title":"Phytochemical profile and pharmacological activity of the dry extract from Arctostaphylos uva-ursi leaves modified with phenylalanine","volume":"6","author":"Chaika","year":"2020","journal-title":"ScienceRise: Pharmaceut. Sci."},{"key":"10.1016\/j.ejps.2024.106712_bib0008","series-title":"Examining Sex and Gender Differences in Anxiety Disorders","author":"Christiansen","year":"2015"},{"key":"10.1016\/j.ejps.2024.106712_bib0009","first-page":"33","volume":"276","year":"2010","journal-title":"Off. J. Eur. Commun. L"},{"issue":"10312","key":"10.1016\/j.ejps.2024.106712_bib0010","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","article-title":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic","volume":"398","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejps.2024.106712_bib0011","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1476-5381.2011.01362.x","article-title":"The age of anxiety: role of animal models of anxiolytic action in drug discovery","volume":"164","author":"Cryan","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejps.2024.106712_bib0012","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1590\/1516-4446-2020-1651","article-title":"Dependence on hypnotics: a comparative study between chronic users of benzodiazepines and Z-drugs","volume":"44","author":"Curado","year":"2022","journal-title":"Revista Brasileira de Psiquiatria (Sao Paulo, Brazil: 1999)"},{"issue":"12","key":"10.1016\/j.ejps.2024.106712_bib0013","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10856-022-06700-4","article-title":"Polymeric nanofibers for drug delivery applications: a recent review","volume":"33","author":"Duan","year":"2022","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.ejps.2024.106712_bib0014","unstructured":"European Pharmacopoeia, 2022. 11th Ed. Council of Europe, Strasbourg."},{"key":"10.1016\/j.ejps.2024.106712_bib0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neuroscience.2015.09.038","article-title":"Tolerance to the sedative and anxiolytic effects of diazepam is associated with different alterations of GABAA receptors in rat cerebral cortex","volume":"310","author":"Ferreri","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejps.2024.106712_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.595584","article-title":"Pharmacotherapy of anxiety disorders: current and emerging treatment options","volume":"11","author":"Garakani","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.ejps.2024.106712_bib0017","series-title":"Guide for the Care and Use of Laboratory Animals","first-page":"246","year":"2011"},{"issue":"10","key":"10.1016\/j.ejps.2024.106712_bib0018","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3390\/pharmaceutics12100983","article-title":"An overview of biopolymeric electrospun nanofibers based on polysaccharides for wound healing management","volume":"12","author":"Iacob","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2024.106712_bib0020","article-title":"Anxiety and depression symptoms after COVID-19 infection: results from the COVID Symptom Study app","author":"Klaser","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.ejps.2024.106712_bib0021","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/plants10020230","article-title":"Phytochemical and psychotropic research of motherwort (Leonurus cardiaca L.) modified dry extracts","volume":"10","author":"Koshovyi","year":"2021","journal-title":"Plants"},{"key":"10.1016\/j.ejps.2024.106712_bib0022","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-4939-8994-2_4","article-title":"The elevated plus maze test for measuring anxiety-like behavior in rodents","volume":"1916","author":"Kraeuter","year":"2019","journal-title":"Method. Mol. Biol."},{"issue":"1","key":"10.1016\/j.ejps.2024.106712_bib0023","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3762\/bjoc.17.57","article-title":"Effective microwave-assisted approach to 1,2,3-triazolobenzodiazepinones via tandem Ugi reaction\/catalyst-free intramolecular azide\u2013alkyne cycloaddition","volume":"17","author":"Mazur","year":"2021","journal-title":"Beilstein J. Org. Chem."},{"issue":"2","key":"10.1016\/j.ejps.2024.106712_bib0024","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s002130100902","article-title":"A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam","volume":"159","author":"Mechan","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejps.2024.106712_bib0025","series-title":"Early Evidence of the Pandemic's Impact","year":"2022"},{"issue":"1","key":"10.1016\/j.ejps.2024.106712_bib0027","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijpharm.2014.12.024","article-title":"Electrospun nanofibers as a potential controlled-release solid dispersion system for poorly water-soluble drugs","volume":"479","author":"Paaver","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ejps.2024.106712_bib0028","article-title":"Pharmacotherapy for depression and anxiety in the primary care setting","volume":"19","author":"Parish","year":"2023","journal-title":"J. Nurse Practition.: JNP"},{"issue":"10277","key":"10.1016\/j.ejps.2024.106712_bib0029","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0140-6736(21)00359-7","article-title":"Anxiety disorders","volume":"397","author":"Penninx","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2024.106712_bib0030","doi-asserted-by":"crossref","unstructured":"Pinna, G., Agis-Balboa, R.C., Zhubi, A., Matsumoto, K., Grayson, D.R., Costa, E., & Guidotti, A., 2006. Imidazenil and diazepam increase locomotor activity in mice exposed to protracted social isolation. Proceedings of the National Academy of Sciences of the United States of America, 103(11), 4275\u20134280. https:\/\/doi.org\/10.1073\/pnas.0600329103.","DOI":"10.1073\/pnas.0600329103"},{"key":"10.1016\/j.ejps.2024.106712_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105224","article-title":"Recent advances in electrospun nanofibers for some biomedical applications","volume":"144","author":"Sabra","year":"2020","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"5","key":"10.1016\/j.ejps.2024.106712_bib0032","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1002\/hsr2.116","article-title":"Benzodiazepine usage and patient preference for alternative therapies: a descriptive study","volume":"2","author":"Sake","year":"2019","journal-title":"Health Sci. Rep."},{"issue":"2","key":"10.1016\/j.ejps.2024.106712_bib0033","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/toxics9020025","article-title":"Benzodiazepines: their use either as essential medicines or as toxics substances","volume":"9","author":"Sanabria","year":"2021","journal-title":"Toxics,"},{"key":"10.1016\/j.ejps.2024.106712_bib0034","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.1957","article-title":"Light\/dark transition test to assess anxiety-like behavior in mice","volume":"6","author":"Serchov","year":"2016","journal-title":"Bio-Protocol."},{"issue":"3","key":"10.1016\/j.ejps.2024.106712_bib0035","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2478\/intox-2013-0020","article-title":"Determination of motor activity and anxiety-related behaviour in rodents: methodological aspects and role of nitric oxide","volume":"6","author":"Sestakova","year":"2013","journal-title":"Interdiscip. Toxicol."},{"key":"10.1016\/j.ejps.2024.106712_bib0036","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2022.08.035","article-title":"Nanoparticles incorporated in nanofibers using electrospinning: a novel nano-in-nano delivery system","volume":"350","author":"Shetty","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2024.106712_bib0037","first-page":"751","article-title":"Phytochemical profile and pharmacological activities of water and hydroethanolic dry extracts of Calluna vulgaris (L.)","volume":"9","author":"Starchenko","year":"2020","journal-title":"Hull. herb. Plants"},{"key":"10.1016\/j.ejps.2024.106712_bib0038","volume":"3","year":"2015"},{"key":"10.1016\/j.ejps.2024.106712_bib0039","series-title":"Preclinical Studies of Drugs","author":"Stefanov","year":"2001"},{"key":"10.1016\/j.ejps.2024.106712_bib0040","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejps.2017.07.001","article-title":"Electrospun polymeric nanofibers: new horizons in drug delivery","volume":"107","author":"Thakkar","year":"2017","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejps.2024.106712_bib0041","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.msec.2017.06.001","article-title":"Electrospinning of gelatin with tunable fiber morphology from round to flat\/ribbon","volume":"80","author":"Topuz","year":"2017","journal-title":"Mater. Sci. Eng.: C"},{"issue":"10","key":"10.1016\/j.ejps.2024.106712_bib0042","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2174\/1567201815666180723114326","article-title":"A summary of electrospun nanofibers as drug delivery system: drugs loaded and biopolymers used as matrices","volume":"15","author":"Torres-Martinez","year":"2018","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejps.2024.106712_bib0043","unstructured":"UKRAINE: IOM RESPONSE 2022-2023, 2023. https:\/\/www.iom.int\/ukraine-iom-response-2022-2023 (accessed 16 June 2023)."},{"key":"10.1016\/j.ejps.2024.106712_bib0044","unstructured":"UNHCR, 2023. Ukraine situation. Retrieved March 1, 2023, from https:\/\/reporting.unhcr.org\/operational\/situations\/ukraine-situation (accessed 16 June 2023)."},{"key":"10.1016\/j.ejps.2024.106712_bib0045","unstructured":"Valium, Valtoco (diazepam) dosing, indications, interactions, adverse effects, and more. (2023, April 13). https:\/\/reference.medscape.com\/drug\/valium-valtoco-diazepam-342902 (accessed 16 June 2023)."},{"key":"10.1016\/j.ejps.2024.106712_bib0046","series-title":"Formation and Characterization of Oleogels Obtained Via Direct Dispersion of Ultrasound-Enhanced Electrospun Nanofibers and Cold milling. Food Structure","author":"Valoppi","year":"2023"},{"key":"10.1016\/j.ejps.2024.106712_bib0047","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pbb.2004.04.017","article-title":"Anxiolytic effects of diazepam and ethanol in two behavioral models: comparison of males and females","volume":"78","author":"Wilson","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejps.2024.106712_bib0048","series-title":"Transforming Mental Health for all","year":"2022"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872400023X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872400023X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:08:49Z","timestamp":1760530129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092809872400023X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":46,"alternative-id":["S092809872400023X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106712","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of nanofiber-based drug delivery systems in improving anxiolytic effect of new 1,2,3-triazolo-1,4-benzodiazepine derivatives","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106712","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106712"}}